新闻和新闻通讯库

以下是本所之前时事通讯的档案。

Patenting stem cells and genes in Europe

21.06.2017

By Wolfgang Weiss and Christian Heubeck, Weickmann & Weickmann. This article first appeared in IAM Life Sciences 2017, a supplement to IAM, published by Globe Business Media Group - IP Division.

尽管英国脱欧,仍会实施统一专利和统一专利法院!

27.02.2017

对我们2016年6月24日和9月26日专业通讯的更新

EPO: Improved refund system for the examination fee after withdrawal of an application

28.10.2016

Obviously as incentive for a withdrawal of applications with low chances of success and/or minor commercial value by the applicants and thus reducing the heavy workload of the EPO, new...

Unitary Patent Protection in Europe on its way and then … Brexit

26.09.2016

By Michael Dey Ph.D., Frank Feller Ph.D., Weickmann & Weickmann PartmbB and John McDonald Ph.D., J.D., Kilpatrick Townsend & Stockton LLP

Key issues in building a strong life sciences patent portfolio

15.07.2016

Innovator companies in the life sciences field need to protect their technology, which often involves development projects for new medicaments.

Community Trademark, Community Design and Unitary Patent – Brexit raises questions over questions

24.06.2016

On June 23, 2016, the British people decided to leave the European Union. This historic decision not only puts the fate of the Unitary Patent System at stake, but also raises questions with respect to the validity of existing...

Displaying results 29 to 35 out of 47